Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8233218 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
Four-year efficacy, cosmesis, and toxicity using 3D-CRT to deliver APBI appear comparable to other experiences with similar follow-up. However, additional patients, further follow-up, and mature Phase III data are needed to evaluate thoroughly the extent of application, limitations, and complete value of this particular form of APBI.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Peter Y. M.D., Michelle R.N., Christina R.N., B.S.N., Inga M.D., Larry M.D., Ashley Fowler, Alvaro M.D., Frank M.D.,